Amol Akhade/X
Oct 29, 2025, 07:13
Amol Akhade: Happy To Share Our Paper Published In Lancet Oncology
Amol Akhade, Senior Medical and Hemato-Oncologist at Fortis Hospital Mumbai and Founder of Suyog Cancer Clinics, shared a post on X:
“Happy To Share Our Paper published In Lancet Oncology. It is joint venture between myself and Manju Sengar and Dr Roni Levin and Daniel Goldstein from Israel .
We closely looked at Subcut IO drugs approvals and discuss that even though sub cut formulations are more convenient they may actually prolong patents and may delay entry of Biosimilar IO drugs.
Wolf in Sheep clothing. Classic essay in Pharmaco Economics”
Title: Subcutaneous immunotherapy—a wolf in sheep’s clothing?
Authors: Roni Levin, Amol Akhade, Manju Sengar, Daniel A Goldstein

Read full paper here
Stay updated with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025
